Finance

Beta
Lists
RKVTF:OTCMKTS
Rakovina Therapeutics Inc
$0.10
0.00%
(0.00) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RKVTF...
Open
$0.10
High
$0.10
Low
$0.10
Mkt. cap
3.30M
Avg. vol.
3.80K
Volume
1.00K
52-wk high
$0.67
52-wk low
$0.04
Shares outstanding
21.15M
Open
$0.10
High
$0.10
Low
$0.10
Mkt. cap
3.30M
Avg. vol.
3.80K
Volume
1.00K
52-wk high
$0.67
52-wk low
$0.04
Shares outstanding
21.15M
News stories
From sources across the web
About Rakovina Therapeutics Inc
CEO-
Employees-
Founded2019
Headquarters-
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.61M
1.10M
828.93K
1.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.21M
539.17K
972.87K
443.99K
Operating expense
2.83M
1.64M
1.80M
1.48M
Total operating expenses
2.83M
1.64M
1.80M
1.48M
Operating income
-2.83M
-1.64M
-1.80M
-1.48M
Other non operating income
-
-
1.00
-
EBT including unusual items
-2.92M
-1.78M
-1.89M
-1.68M
EBT excluding unusual items
-2.92M
-1.78M
-1.91M
-1.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.92M
-1.78M
-1.89M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
773.00
-
Interest expense
-91.69K
-139.75K
-108.48K
-101.81K
Net interest expenses
-91.69K
-139.75K
-107.70K
-101.81K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.69M
-1.51M
-1.67M
-1.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more